US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jun 29, 2012 (14 years ago)

Mercaptopurine Tablets, USP, 50 mg, packaged in a) 60-count tablets per bottle (NDC…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed USP Dissolution Test Requirements: The recalled lots do not meet the specification for dissolution.

What was recalled

Mercaptopurine Tablets, USP, 50 mg, packaged in a) 60-count tablets per bottle (NDC 49884-922-02) and b) 250-count tablets per bottle (NDC 49884-922-04), Rx only, Distributed by: Par Pharmaceutical Companies, Inc., Spring Valley, NY 10977.

Recalling firm
Prometheus Laboratories Inc.
NDC code
49884-922-02
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1659-2012

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Mercaptopurine recalls

See all